Knockdown of Shp2 promoted ESCC cell proliferation in vitro and the growth of xenografts in vivo, indicating the anti-proliferation role of Shp2 in human ESCC. This evidence concerns the gene PTPN11 and esophageal squamous cell carcinoma.